Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
OSPEMIFENE
(2013)
Small molecule
Estrogen receptor modulator
ORAL
Approved
Atrophy; Dyspareunia; Menopause
OSPEMIFENE
×
Maximum Phase:
4
First Approval:
2013
UNII:
B0P231ILBK
Molecule Type:
Small molecule
Molecular Formula:
C24H23ClO2
Molecular Weight:
378.9
AlogP:
5.65
PSA:
29.46
HBD:
1.0
HBA:
#RotB:
8.0
Source:
DOLUTEGRAVIR
(2013)
Small molecule
Unknown
ORAL
Approved
Virus Diseases
DOLUTEGRAVIR
×
Maximum Phase:
4
First Approval:
2013
UNII:
DKO1W9H7M1
Molecule Type:
Small molecule
Molecular Formula:
C20H19F2N3O5
Molecular Weight:
419.38
AlogP:
1.35
PSA:
100.87
HBD:
2.0
HBA:
#RotB:
3.0
Source:
LEVOMILNACIPRAN HYDROCHLORIDE
(2013)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depressive Disorder, Major; Fibromyalgia
LEVOMILNACIPRAN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2013
UNII:
371U2ZK31U
Molecule Type:
Small molecule
Molecular Formula:
C15H23ClN2O
Molecular Weight:
282.81
AlogP:
1.77
PSA:
46.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
OMEGA-3-CARBOXYLIC ACIDS
(2014)
Small molecule
Unknown
ORAL
Approved
Unknown
OMEGA-3-CARBOXYLIC ACIDS
×
Maximum Phase:
4
First Approval:
2014
UNII:
F85N2YHE4E
Molecule Type:
Small molecule
Molecular Formula:
C181H286O18
Molecular Weight:
2750.26
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SUVOREXANT
(2014)
Small molecule
Orexin receptor antagonist
ORAL
Approved
Sleep Initiation and Maintenance Disorders
SUVOREXANT
×
Maximum Phase:
4
First Approval:
2014
UNII:
081L192FO9
Molecule Type:
Small molecule
Molecular Formula:
C23H23ClN6O2
Molecular Weight:
450.93
AlogP:
4.11
PSA:
80.29
HBD:
0.0
HBA:
#RotB:
3.0
Source:
CEFTOLOZANE
(2014)
Small molecule
Unknown
Unknown
Approved
Unknown
CEFTOLOZANE
×
Maximum Phase:
4
First Approval:
2014
UNII:
37A4IES95Q
Molecule Type:
Small molecule
Molecular Formula:
C23H30N12O8S2
Molecular Weight:
666.7
AlogP:
-3.9
PSA:
302.21
HBD:
7.0
HBA:
#RotB:
12.0
Source:
FLORBETABEN F18
(2014)
Small molecule
Diagnostic agent
Unknown
Approved
Alzheimer Disease; Cognitive Dysfunction
FLORBETABEN F18
×
Maximum Phase:
4
First Approval:
2014
UNII:
TLA7312TOI
Molecule Type:
Small molecule
Molecular Formula:
C21H26FNO3
Molecular Weight:
358.44
AlogP:
4.28
PSA:
39.72
HBD:
1.0
HBA:
#RotB:
12.0
Source:
PERAMIVIR
(2014)
Small molecule
Neuraminidase inhibitor
INTRAVENOUS
Approved
Influenza, Human; Virus Diseases
PERAMIVIR
×
Maximum Phase:
4
First Approval:
2014
UNII:
QW7Y7ZR15U
Molecule Type:
Small molecule
Molecular Formula:
C15H34N4O7
Molecular Weight:
382.46
AlogP:
-0.14
PSA:
148.53
HBD:
6.0
HBA:
#RotB:
7.0
Source:
DAPAGLIFLOZIN
(2014)
Small molecule
Sodium/glucose cotransporter 2 inhibitor
ORAL
Approved
Diabetes Mellitus
DAPAGLIFLOZIN
×
Maximum Phase:
4
First Approval:
2014
UNII:
1ULL0QJ8UC
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClO6
Molecular Weight:
408.88
AlogP:
1.84
PSA:
99.38
HBD:
4.0
HBA:
#RotB:
6.0
Source:
IDELALISIB
(2014)
Small molecule
PI3-kinase p110-delta subunit inhibitor
ORAL
Approved
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Neoplasms
IDELALISIB
×
Maximum Phase:
4
First Approval:
2014
UNII:
YG57I8T5M0
Molecule Type:
Small molecule
Molecular Formula:
C22H18FN7O
Molecular Weight:
415.43
AlogP:
3.75
PSA:
101.38
HBD:
2.0
HBA:
#RotB:
5.0
Source:
VORAPAXAR SULFATE
(2014)
Small molecule
Proteinase-activated receptor 1 antagonist
ORAL
Approved
Myocardial Infarction; Peripheral Arterial Disease; Stroke
VORAPAXAR SULFATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
IN66038E6C
Molecule Type:
Small molecule
Molecular Formula:
C29H35FN2O8S
Molecular Weight:
590.67
AlogP:
5.63
PSA:
77.52
HBD:
1.0
HBA:
#RotB:
5.0
Source:
OMBITASVIR
(2014)
Small molecule
Nonstructural protein 5A inhibitor
Unknown
Approved
Hepatitis C; Hepatitis C, Chronic
OMBITASVIR
×
Maximum Phase:
4
First Approval:
2014
UNII:
2302768XJ8
Molecule Type:
Small molecule
Molecular Formula:
C50H67N7O8
Molecular Weight:
894.13
AlogP:
7.69
PSA:
178.72
HBD:
4.0
HBA:
#RotB:
13.0
Source:
EMPAGLIFLOZIN
(2014)
Small molecule
Sodium/glucose cotransporter 2 inhibitor
ORAL
Approved
Diabetes Mellitus; Diabetes Mellitus, Type 2
EMPAGLIFLOZIN
×
Maximum Phase:
4
First Approval:
2014
UNII:
HDC1R2M35U
Molecule Type:
Small molecule
Molecular Formula:
C23H27ClO7
Molecular Weight:
450.92
AlogP:
1.61
PSA:
108.61
HBD:
4.0
HBA:
#RotB:
6.0
Source:
TASIMELTEON
(2014)
Small molecule
Melatonin receptor agonist
ORAL
Approved
Sleep Wake Disorders; Smith-Magenis Syndrome
TASIMELTEON
×
Maximum Phase:
4
First Approval:
2014
UNII:
SHS4PU80D9
Molecule Type:
Small molecule
Molecular Formula:
C15H19NO2
Molecular Weight:
245.32
AlogP:
2.25
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
4.0
Source:
NALOXEGOL
(2014)
Small molecule
Unknown
Unknown
Approved
Constipation
NALOXEGOL
×
Maximum Phase:
4
First Approval:
2014
UNII:
44T7335BKE
Molecule Type:
Small molecule
Molecular Formula:
C34H53NO11
Molecular Weight:
651.79
AlogP:
1.86
PSA:
126.77
HBD:
2.0
HBA:
#RotB:
24.0
Source:
SODIUM GLYCEROPHOSPHATE
(2014)
Small molecule
Unknown
Unknown
Approved
Unknown
SODIUM GLYCEROPHOSPHATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
RCS9EQ01V4
Molecule Type:
Small molecule
Molecular Formula:
C3H7Na2O6P
Molecular Weight:
216.04
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
EFINACONAZOLE
(2014)
Small molecule
Lanosterol 14-alpha demethylase inhibitor
TOPICAL
Approved
Onychomycosis
EFINACONAZOLE
×
Maximum Phase:
4
First Approval:
2014
UNII:
J82SB7FXWB
Molecule Type:
Small molecule
Molecular Formula:
C18H22F2N4O
Molecular Weight:
348.4
AlogP:
2.48
PSA:
54.18
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CERITINIB
(2014)
Small molecule
ALK tyrosine kinase receptor inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung; Neoplasms
CERITINIB
×
Maximum Phase:
4
First Approval:
2014
UNII:
K418KG2GET
Molecule Type:
Small molecule
Molecular Formula:
C28H36ClN5O3S
Molecular Weight:
558.15
AlogP:
6.36
PSA:
105.24
HBD:
3.0
HBA:
#RotB:
9.0
Source:
PARITAPREVIR
(2014)
Small molecule
Hepatitis C virus serine protease, NS3/NS4A inhibitor
Unknown
Approved
Hepatitis C; Hepatitis C, Chronic
PARITAPREVIR
×
Maximum Phase:
4
First Approval:
2014
UNII:
OU2YM37K86
Molecule Type:
Small molecule
Molecular Formula:
C40H43N7O7S
Molecular Weight:
765.89
AlogP:
3.64
PSA:
189.65
HBD:
3.0
HBA:
#RotB:
7.0
Source:
TESTOSTERONE UNDECANOATE
(2014)
Small molecule
Androgen Receptor agonist
INTRAMUSCULAR; ORAL
Approved
Hypogonadism; Klinefelter Syndrome; Neoplasms; Orchitis
TESTOSTERONE UNDECANOATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
H16A5VCT9C
Molecule Type:
Small molecule
Molecular Formula:
C30H48O3
Molecular Weight:
456.71
AlogP:
7.96
PSA:
43.37
HBD:
0.0
HBA:
#RotB:
10.0
Source:
BELINOSTAT
(2014)
Small molecule
Histone deacetylase inhibitor
INTRAVENOUS
Approved
Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Neoplasms
BELINOSTAT
×
Maximum Phase:
4
First Approval:
2014
UNII:
F4H96P17NZ
Molecule Type:
Small molecule
Molecular Formula:
C15H14N2O4S
Molecular Weight:
318.35
AlogP:
2.01
PSA:
95.5
HBD:
3.0
HBA:
#RotB:
5.0
Source:
LEDIPASVIR
(2014)
Small molecule
Nonstructural protein 5A inhibitor
Unknown
Approved
Hepatitis C; Hepatitis C, Chronic
LEDIPASVIR
×
Maximum Phase:
4
First Approval:
2014
UNII:
013TE6E4WV
Molecule Type:
Small molecule
Molecular Formula:
C49H54F2N8O6
Molecular Weight:
889.02
AlogP:
8.61
PSA:
174.64
HBD:
4.0
HBA:
#RotB:
10.0
Source:
NETUPITANT
(2014)
Small molecule
Neurokinin 1 receptor antagonist
Unknown
Approved
Postoperative Nausea and Vomiting
NETUPITANT
×
Maximum Phase:
4
First Approval:
2014
UNII:
7732P08TIR
Molecule Type:
Small molecule
Molecular Formula:
C30H32F6N4O
Molecular Weight:
578.6
AlogP:
6.79
PSA:
39.68
HBD:
0.0
HBA:
#RotB:
5.0
Source:
FINAFLOXACIN
(2014)
Small molecule
DNA gyrase inhibitor
OTIC
Approved
Unknown
FINAFLOXACIN
×
Maximum Phase:
4
First Approval:
2014
UNII:
D26OSN9Q4R
Molecule Type:
Small molecule
Molecular Formula:
C20H19FN4O4
Molecular Weight:
398.39
AlogP:
1.22
PSA:
107.59
HBD:
2.0
HBA:
#RotB:
3.0
Source:
DASABUVIR SODIUM
(2014)
Small molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
Unknown
Approved
Hepatitis C; Hepatitis C, Chronic
DASABUVIR SODIUM
×
Maximum Phase:
4
First Approval:
2014
UNII:
OG6D40M62L
Molecule Type:
Small molecule
Molecular Formula:
C26H28N3NaO6S
Molecular Weight:
533.58
AlogP:
4.02
PSA:
110.26
HBD:
2.0
HBA:
#RotB:
5.0
Source:
NINTEDANIB ESYLATE
(2014)
Small molecule
Fibroblast growth factor receptor inhibitor
Unknown
Approved
Idiopathic Pulmonary Fibrosis; Scleroderma, Systemic
NINTEDANIB ESYLATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
42F62RTZ4G
Molecule Type:
Small molecule
Molecular Formula:
C33H39N5O7S
Molecular Weight:
649.77
AlogP:
3.62
PSA:
94.22
HBD:
2.0
HBA:
#RotB:
7.0
Source:
NINTEDANIB
(2014)
Small molecule
Unknown
Unknown
Approved
Idiopathic Pulmonary Fibrosis; Neoplasms
NINTEDANIB
×
Maximum Phase:
4
First Approval:
2014
UNII:
G6HRD2P839
Molecule Type:
Small molecule
Molecular Formula:
C31H33N5O4
Molecular Weight:
539.64
AlogP:
3.62
PSA:
94.22
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MILTEFOSINE
(2014)
Small molecule
Unknown
ORAL
Approved
Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Trypanosomiasis
MILTEFOSINE
×
Maximum Phase:
4
First Approval:
2014
UNII:
53EY29W7EC
Molecule Type:
Small molecule
Molecular Formula:
C21H46NO4P
Molecular Weight:
407.58
AlogP:
5.68
PSA:
58.59
HBD:
0.0
HBA:
#RotB:
20.0
Source:
DROXIDOPA
(2014)
Small molecule
Adrenergic receptor agonist
ORAL
Approved
Cardiovascular Diseases; Hypotension, Orthostatic; Multiple System Atrophy
DROXIDOPA
×
Maximum Phase:
4
First Approval:
2014
UNII:
J7A92W69L7
Molecule Type:
Small molecule
Molecular Formula:
C9H11NO5
Molecular Weight:
213.19
AlogP:
-0.46
PSA:
124.01
HBD:
5.0
HBA:
#RotB:
3.0
Source:
OLODATEROL
(2014)
Small molecule
Unknown
Unknown
Approved
Lung Diseases, Obstructive
OLODATEROL
×
Maximum Phase:
4
First Approval:
2014
UNII:
VD2YSN1AFD
Molecule Type:
Small molecule
Molecular Formula:
C21H26N2O5
Molecular Weight:
386.45
AlogP:
2.38
PSA:
100.05
HBD:
4.0
HBA:
#RotB:
7.0
Source:
NALOXEGOL OXALATE
(2014)
Small molecule
Mu opioid receptor antagonist
ORAL
Approved
Cancer Pain; Constipation
NALOXEGOL OXALATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
65I14TNM33
Molecule Type:
Small molecule
Molecular Formula:
C36H55NO15
Molecular Weight:
741.83
AlogP:
1.86
PSA:
126.77
HBD:
2.0
HBA:
#RotB:
24.0
Source:
FLORBETABEN
(2014)
Small molecule
Unknown
Unknown
Approved
Unknown
FLORBETABEN
×
Maximum Phase:
4
First Approval:
2014
UNII:
BMO5G62HGB
Molecule Type:
Small molecule
Molecular Formula:
C21H26FNO3
Molecular Weight:
359.44
AlogP:
4.28
PSA:
39.72
HBD:
1.0
HBA:
#RotB:
12.0
Source:
OLAPARIB
(2014)
Small molecule
PARP 1, 2 and 3 inhibitor
ORAL
Approved
Neoplasms; Ovarian Neoplasms
OLAPARIB
×
Maximum Phase:
4
First Approval:
2014
UNII:
WOH1JD9AR8
Molecule Type:
Small molecule
Molecular Formula:
C24H23FN4O3
Molecular Weight:
434.47
AlogP:
2.35
PSA:
86.37
HBD:
1.0
HBA:
#RotB:
4.0
Source:
FERRIC CITRATE
(2014)
Small molecule
Phosphate sequestering agent
ORAL
Approved
Unknown
FERRIC CITRATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
63G354M39Z
Molecule Type:
Small molecule
Molecular Formula:
C6H7FeO8
Molecular Weight:
262.96
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TAVABOROLE
(2014)
Small molecule
Leucine-tRNA ligase inhibitor
TOPICAL
Approved
Onychomycosis
TAVABOROLE
×
Maximum Phase:
4
First Approval:
2014
UNII:
K124A4EUQ3
Molecule Type:
Small molecule
Molecular Formula:
C7H6BFO2
Molecular Weight:
151.93
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
VORAPAXAR
(2014)
Small molecule
Unknown
Unknown
Approved
Thrombosis
VORAPAXAR
×
Maximum Phase:
4
First Approval:
2014
UNII:
ZCE93644N2
Molecule Type:
Small molecule
Molecular Formula:
C29H33FN2O4
Molecular Weight:
492.59
AlogP:
5.63
PSA:
77.52
HBD:
1.0
HBA:
#RotB:
5.0
Source:
1
2
…
63
64
65
66
67
68
69
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA